Frequently Asked Questions
Direct answers about beverage formulation, first runs, product changes, validation production, consumer feedback, ownership, and commercial boundaries.
Liquid Labs connects product strategy, claims planning, formulation, ingredient qualification, consumer feedback, production-like samples, pilot validation, validation-scale production, commercial readiness, and fractional beverage operations.
No. A recipe is one component of a commercially ready beverage system. The product brief, ingredients, claims, formula, process, package, consumer evidence, quality specifications, cost model, production plan, and operating responsibilities must align.
Ideally before committing printed packaging, large ingredient orders, production slots, distributor promises, or saleable inventory. Existing brands should also make contact before implementing a material supplier, formula, package, process, or co-manufacturer change.
Yes, subject to product eligibility and a signed scope. The facility is designed to help brands translate formulas into production-like samples and validation runs before making a larger commercial commitment.
Yes. Liquid Labs can support reformulation, supplier substitutions, flavor changes, active changes, cost-reduction work, package changes, process changes, quality corrections, and co-manufacturer transitions.
The facility provides dedicated room for formulation, sample production, staging, validation work, and process documentation while remaining intentionally right-sized for controlled learning rather than high-volume commodity production.
An R&D sample run creates a small quantity of production-like samples, generally around 50–200 cans per SKU. A validation run, generally around 2,000–20,000 cans per SKU, is designed to evaluate the intended process, package, dosing, carbonation, thermal treatment, quality controls, and release assumptions.
No. Shelf-life conclusions must be tied to the actual formula, intended process, intended package, test protocol, acceptance criteria, and sufficient real-time or category-appropriate evidence. Accelerated work is an early screen, not a universal guarantee.
No. Liquid Labs may provide technical issue-spotting, documentation support, formula and claims alignment, and coordination. Final legal conclusions, regulatory determinations, labels, claims, registrations, licenses, and market-entry decisions remain with the client and qualified advisors.
Not by default. Findings are directional unless a study is expressly designed, sampled, and priced as statistically powered or representative.
Subject to the governing agreement and payment in full, the client generally owns the final approved product-specific formula created for the client. Liquid Labs retains its general methods, templates, calculators, systems, supplier knowledge, production approaches, and background know-how.
Liquid Labs is primarily designed for formulation, R&D sample production, first controlled runs, pilot validation, and small-to-mid validation production. Any commercial-production scope, capacity, product eligibility, timing, and release requirements must be expressly approved in a product-specific statement of work.
Potentially, subject to the product, formula, licenses, documentation, facility permissions, intended markets, testing requirements, and applicable laws. An inquiry does not constitute product acceptance.
Not by default. Such a concept requires separate legal and regulatory review, required licenses and approvals, and express written acceptance. Liquid Labs may decline the product.
No such status should be assumed. Liquid Labs operates a shared facility. Any free-from claim, special certification, segregation standard, residue control, testing protocol, or release criterion must be defined and approved in writing.
Not unless expressly included in the signed scope. These items are commonly priced or passed through separately so the economics of development, research, production, materials, and third-party services remain visible.
No. The system is designed to create better evidence, clearer decisions, stronger documentation, and fewer avoidable surprises—not to guarantee a market outcome.
A supplier, ingredient, flavor, active load, sweetener, acid, preservative, package, process, carbonation, thermal treatment, claim, or co-manufacturer change may affect the wider product system and should be assessed accordingly.